Eton Pharmaceuticals, Inc.
ETON · NASDAQ
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $584,385 | $383,225 | $348,980 | $348,132 |
| - Cash | $37,121 | $25,379 | $17,420 | $14,936 |
| + Debt | $3,256 | $30,670 | $30,079 | $29,918 |
| Enterprise Value | $550,520 | $388,516 | $361,639 | $363,114 |
| Revenue | $22,459 | $18,928 | $17,282 | $11,647 |
| % Growth | 18.7% | 9.5% | 48.4% | – |
| Gross Profit | $7,855 | $11,924 | $9,861 | $6,476 |
| % Margin | 35% | 63% | 57.1% | 55.6% |
| EBITDA | $266 | -$470 | $543 | $984 |
| % Margin | 1.2% | -2.5% | 3.1% | 8.4% |
| Net Income | -$1,927 | -$2,585 | -$1,572 | -$598 |
| % Margin | -8.6% | -13.7% | -9.1% | -5.1% |
| EPS Diluted | -0.07 | -0.096 | -0.059 | -0.023 |
| % Growth | 27.2% | -64.3% | -155.5% | – |
| Operating Cash Flow | $12,026 | $7,959 | $2,090 | -$765 |
| Capital Expenditures | -$284 | $0 | $0 | -$12 |
| Free Cash Flow | $11,742 | $7,959 | $2,090 | -$777 |